Twenty-one patients whose severe ventricular arrhythmias were not controlled by other
currently used antiarrhythmic agents or who were intolerant of those drugs were treated with a …

To determine the efficacy of the newer antiarrhythmic drug propafenone and to compare it to
disopyramide, sixteen patients--11 men and 5 women--participated in a randomized double-…

The antiarrhythmic efficacy and safety of intravenous amiodarone were evaluated in 13
patients with recurrent sustained ventricular tachycardia. All patients had been refractory to at …

FOOTE MJG: Unusual use of ultrasound in a paranoid patient (L) 1332 MASTERS AB: Genetics
and a woman's rights (L) 1433 NEWS AND FEATURES: Are pro-lifers affecting number …

OBJECTIVE--To assess the clinical criteria predicting the short and long-term efficacy of
propafenone, an agent with class IC antiarrhythmic activity and a broad pharmacological profile. …

In South Africa, learners’ standard of reading in the Intermediate Phase (Grades 4 to 6) is
cause for considerable concern. The 2016-PIRLS findings have provided overwhelming …

GUI30 CAPELLA, MD PEDRO BRUGADA, MD HEIN JJ WELLENS, MD t lectrophysiologic
studies have evaluated retrograde conduction over the atrioventricular (AV] conduction …

Thirty-two men with chronic ventricular arrhythmias responded to propafenone, a new potent
antiarrhythmic agent, in short-term trials with 85% or greater reduction of total ventricular …

PROPAFENONE HYDROCHLORIDE (Rythmol) is an antiarrhythmic drug that has been
extensively used in Europe and has recently been approved for oral use in the United States for …

Propafenone is a new class Ic antiarrhythmic compound with a broad pharmacologic profile.
In this study, its dose-response relationship was examined in a double-blind, randomized, …